Projects per year
Organization profile
Organisation profile
The TMU Research Center of Cancer Translational Medicine (RCCTM) is established through combining all cancer-related resources of TMU and its three affiliated hospitals. RCCTM is established with the goal of translating the research discoveries into state-of-the-art therapeutics for the prevention and treatment of cancer, as well as training future oncologists. We are committed to reduce the cancer burden through skilled, integrated and compassionate clinical care, and to eliminate the threat of cancer through research and education.
Fingerprint Dive into the research topics where TMU Research Center of Cancer Translational Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects
To Develop Novel Treatment Options for Hepatocellular Carcinoma via Drug Repurposing(2/2)
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
奈米HEVnp於晚期大腸直腸癌患者的治療策略(1/3)相對補助
8/1/19 → 7/31/20
Project: A - Government Institution › f - Other (Funded by Government)
Investigating the Oncogenic Roles of A9-Nicotinic Acetylcholine Receptor Variants on Breast Cancer( III )
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output
ABL genomic editing sufficiently abolishes oncogenesis of human chronic myeloid leukemia cells in vitro and in vivo
Chen, S. H., Hsieh, Y. Y., Tzeng, H. E., Lin, C. Y., Hsu, K. W., Chiang, Y. S., Lin, S. M., Su, M. J., Hsieh, W. S. & Lee, C. H., Jun 2020, In : Cancers. 12, 6, 1399.Research output: Contribution to journal › Article
Open Access
A Key Role of DNA Damage-Inducible Transcript 4 (DDIT4) Connects Autophagy and GLUT3-Mediated Stemness To Desensitize Temozolomide Efficacy in Glioblastomas
Ho, K. H., Chen, P. H., Chou, C. M., Shih, C. M., Lee, Y. T., Cheng, C. H. & Chen, K. C., Jan 1 2020, (Accepted/In press) In : Neurotherapeutics.Research output: Contribution to journal › Article
Anaplastic lymphoma kinase inhibitors: an updated patent review (2014–2018)
Liu, Y. M., Kuo, C. N. & Liou, J. P., Jan 1 2020, (Accepted/In press) In : Expert Opinion on Therapeutic Patents.Research output: Contribution to journal › Review article